Sleep apnea: Zepbound, Mounjaro improves symptoms in clinical trial – Medical News Today
- Sleep apnea: Zepbound, Mounjaro improves symptoms in clinical trial Medical News Today
- Sleep Apnea Reduced in People Who Took Weight-Loss Drug, Eli Lilly Reports The New York Times
- Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says CNN
- Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity | Eli Lilly and Company Investors | Eli Lilly and Company
- Eli Lilly: Zepbound effective for sleep apnea, trial finds Business Insider